Immune Pharmaceuticals to transfer common stock listing from NASDAQ OMX Stockholm Exchange

Download PDF Copy

Editorial Checklist

Reviewed

Immune Pharmaceuticals Inc.Nov 26 2013

Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that its common stock has been approved for trading on NASDAQ OMX First North Premier, Stockholm ("First North"). The Company will transfer its common stock listing from the NASDAQ OMX Stockholm Exchange on November 29, 2013, and the first day of trading on First North will be December 2, 2013.

Erik Penser Bankaktiebolag is engaged as Immune´s Certified Adviser on First North. A Company description has been prepared in accordance with First North´s rules and will be made available on Immune´s website.

Source:

Immune Pharmaceuticals Inc.

Posted in: Business / Finance

Tags: Antibodies, Antibody, Asthma, Cancer, Crohn's Disease, Immune System, Oncology, Pharmaceuticals, Ulcerative Colitis

Comments (0)

Download PDF Copy

Suggested Reading

Research from second pig heart transplant provides new directions for xenotransplantation

Research from second pig heart transplant provides new directions for xenotransplantation

Study reveals how fatty liver disease leads to liver cancer

Study reveals how fatty liver disease leads to liver cancer

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

U.S. wastewater treatment fails to address rising organofluorine contamination

U.S. wastewater treatment fails to address rising organofluorine contamination

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Psilocybin shows potential for treating mental health disorders in people with cancer and addiction

Psilocybin shows potential for treating mental health disorders in people with cancer and addiction

Danish studies find increased risk of optic nerve damage with diabetes medicine

Danish studies find increased risk of optic nerve damage with diabetes medicine

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Carrots may offer natural support for people with type 2 diabetes